With a market cap of 97.5 B, Celgene Corporation has a large market cap size. Celgene Corporation (NASDAQ: CELG) has been on the stock market since its IPO date on the 3/26/1990. Celgene Corporation is in the Biotechnology industry and Healthcare sector. Average volume for Celgene Corporation, is 3497.8, and so far today it has a volume of 5971963. Performance year to date since the 3/26/1990 is 8.13%.
To help you determine whether Celgene Corporation is undervalued the following values will help you decide. P/E is 47.14 and forward P/E is 14.2. PEG perhaps more useful shows that Celgene Corporation has a value for PEG of 2.28. P/S ratio is 8.35 and the P/B ratio is 12.76. The P/Cash and P/Free cash flow is 11 and 36.44 respectively.
At the current price Celgene Corporation is trading at, 125.16 (2.29% today), Celgene Corporation has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 2.66, and this is looking to grow in the next year to 20.99% after growing 28.10% this past year. EPS growth quarter over quarter is 17.00%, and 17.90% for sales growth quarter over quarter.
The number of shares outstanding is 779, and the number of shares float is 778.91. The senior management bring insider ownership to 0.20%, and institutional ownership is at 80.10%. The float short is 1.22%, with the short ratio at a value of 2.71. Management has seen a return on assets of 7.80%, and also a return on investment of 11.70%.
The ability for Celgene Corporation, to deal with debt, means it current ratio is 4.4, and quick ratio is 4.2. Long term debt/equity is 1.8 and total debt/equity is 1.87. In terms of margins, Celgene Corporation has a gross margin of 96.20%, with its operating margin at 24.80%, and Celgene Corporation has a profit margin of 18.30%.
The 52 week high is -1.94%, with 32.56% being its 52 week low. The 20 day simple moving average is 6.22% and the 200 day simple moving average is 7.93%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.